Persian honeylocust ointment in hemorrhoids

Phase 2

Recruiting

• Conditions: Hemorrhoid.; Other hemorrhoids; K64.8

• Registration Number: IRCT20220122053783N1
• Lead Sponsor: Ardabil University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 8 March 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with grade 1-2 internal hemorrhoids
Age 18-65 years
Patients with bleeding or hemorrhoidal prolapse or pain or two or all together
Have a signed informed consent form to participate in the study

Exclusion Criteria

Anorectal diseases such as rectal prolapse, Fisher, fistula, perianal abscess
Thrombosis and gangrenous hemorrhoids
Uncontrolled cardiovascular disease
Cirrhosis
Inflammatory bowel disease (IBD)
Pregnancy and lactation
History of allergy to herbal medicines
Use analgesics less than a week ago
Use of anticoagulants less than a month ago
Use of steroid less than a month ago
Unwillingness to participate in the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain according to CORECTS questionnaire. Timepoint: At the first (before starting the study), end of the first and the second week. Method of measurement: Colo-Rectal Evaluation of Clinical Therapeutics Scale (CORECTS) questionnaire.;Rectorrhagia according to CORECTS questionnaire. Timepoint: At the fist (before starting the study), end of the first and the second week. Method of measurement: Colo-Rectal Evaluation of Clinical Therapeutics Scale (CORECTS) questionnaire.

Secondary Outcome Measures

Name	Time	Method
Itching according to CORECTS questionnaire. Timepoint: At the fist (before starting the study), end of the first and the second week. Method of measurement: Colo-Rectal Evaluation of Clinical Therapeutics Scale (CORECTS) questionnaire.;Quality of Life. Timepoint: At the fist (before starting the study), end of the first and the second week. Method of measurement: The World Health Organization Quality of Life Instrument, Short Form (WHOQOL-BREF) questionnaire.;Possible side effects of treatment. Timepoint: At the fist (before starting the study), end of the first and the second week. Method of measurement: Researcher-made questionnaire.;Satisfaction of treatment. Timepoint: At the fist (before starting the study), end of the first and the second week. Method of measurement: Researcher-made questionnaire (according to Visual Analogue Scale).